BCL11A confers cell invasion and migration in androgen receptor‑positive triple‑negative breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

BCL11A confers cell invasion and migration in androgen receptor‑positive triple‑negative breast cancer

Published:2020-02-10 Issue: Volume: Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Wang Xin¹,Xu Yumei²,Xu Kun³,Chen Yajuan⁴,Xiao Xiudi⁵,Guan Xiaoxiang¹

Affiliation:

1. Department of Medical Oncology, Jinling Hospital, Medical School of Nanjing University, Nanjing, Jiangsu 210002, P.R. China

2. Department of Gynaecology and Obstetrics, Zhongshan People's Hospital, Zhongshan, Guangdong 528403, P.R. China

3. Department of Oncology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, P.R. China

4. Department of Medical Oncology, Jinling Clinical College of Nanjing Medical University, Nanjing, Jiangsu 210002, P.R. China

5. Department of Breast Surgery, Affiliated People's Hospital of Jiangsu University, Zhenjiang, Jiangsu 212002, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A feedback loop between lncRNA MALAT1 and DNMT1 promotes triple-negative breast cancer stemness and tumorigenesis;Cancer Biology & Therapy;2023-08-07

2. RNA-seq analysis reveals candidate genes associated with proliferation, invasion, and migration in BCL11A knockdown B-NHL cell lines;Annals of Hematology;2023-05-06

3. Invention of 3Mint for feature grouping and scoring in multi-omics;Frontiers in Genetics;2023-03-15

4. Triple-negative Breast Cancer: Identification of circRNAs With Efficacy in PreclinicalIn VivoModels;Cancer Genomics - Proteomics;2023-03

5. BCL11A Facilitates Cell Proliferation and Metastasis in Neuroblastoma via Regulating the PI3K/Akt Signaling Pathway;Current Cancer Drug Targets;2022-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3